Skip to Main content Skip to Navigation
Journal articles

Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells

Abstract : Cancer cells are characterized by the Warburg effect, a shift from mitochondrial respiration to oxidative glycolysis. We report here the crucial role of cyclin D1 in promoting this effect in a cyclin-dependent kinase (CDK)4/6-independent manner in multiple myeloma (MM) cells. We show that the cyclin D1 oncoprotein targets hexokinase 2 (HK2), a major glycolysis regulator, through two original molecular mechanisms in the cytoplasmic and nuclear compartments. In the cytoplasm, cyclin D1 binds HK2 at the outer mitochondrial membrane, and in the nucleus, it binds hypoxia-inducible factor-1α (HIF1α), which regulates HK2 gene transcription. We also show that high levels of HK2 expression are correlated with shorter event-free survival (EFS) and overall survival (OS) in MM patients. HK2 may therefore be considered as a possible target for antimyeloma therapy.
Document type :
Journal articles
Complete list of metadata

Cited literature [42 references]  Display  Hide  Download
Contributor : Brigitte Sola Connect in order to contact the contributor
Submitted on : Tuesday, July 28, 2020 - 12:57:08 PM
Last modification on : Thursday, August 4, 2022 - 4:56:04 PM
Long-term archiving on: : Tuesday, December 1, 2020 - 8:55:00 AM


Caillot Oncogenesis 2020.pdf
Publisher files allowed on an open archive



M. Caillot, J. Bourgeais, H. Dakik, É. Costé, N. Mazure, et al.. Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells. Oncogenesis, Nature Publishing Group: Open Access Journals - Option C, 2020, 9 (7), pp.68. ⟨10.1038/s41389-020-00253-3⟩. ⟨hal-02908131⟩



Record views


Files downloads